SCHEMBL233084

SCHEMBL233084

F[C@@H]1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL231907 1.00
SCHEMBL305052 1.00
SCHEMBL31250263 1.00
Hydrochloric Acid SCHEMBL389357 0.97
Hydrochloric Acid SCHEMBL3579403 0.97
Hydrochloric Acid SCHEMBL389356 0.97
Hydrochloric Acid SCHEMBL717319 0.97
Hydrochloric Acid SCHEMBL4143518 0.94
Urea SCHEMBL20873109 0.84 KDM4E (0.43)
Dimethyl Sulfoxide SCHEMBL28843989 0.84 KCNH2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532014-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Cerevance, Inc. (US) 2025-04-09 EP claimed
WO-2023227867-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Cerevance, Inc. (US) 2023-11-30 WO claimed
EP-3774760-A1 PLADIENOLIDE DERIVATIVES AS SPLICEOSOME TARGETING AGENTS FOR TREATING CANCER Eisai R&D Management Co., Ltd. (JP) 2021-02-17 EP claimed
EP-3298012-B1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS PLEXXIKON INC (US) 2020-09-02 EP claimed
WO-2019200100-A1 PLADIENOLIDE DERIVATIVES AS SPLICEOSOME TARGETING AGENTS FOR TREATING CANCER COOK ANDREW (US) 2019-10-17 WO claimed
WO-2011119340-A1 SMART CONTRAST AGENT AND METHOD FOR DETECTING TRANSITION METAL IONS AND TREATING RELATED DISORDERS I.S.T. CORPORATION (JP) 2011-09-29 WO claimed
US-20100227794-A1 SMART CONTRAST AGENT AND METHOD FOR DETECTING TRANSITION METAL IONS AND TREATING RELATED DISORDERS I.S.T. CORPORATION (JP) 2010-09-09 US claimed
EP-4027995-B1 HPK1 ANTAGONISTS AND USES THEREOF NIMBUS SATURN INC (US) 2026-05-27 EP disclosed
CN-122070273-A Novel process for the preparation of (3R) -fluoropyrrolidine hydrochloride 豪夫迈·罗氏有限公司 2026-05-19 CN disclosed
US-20260132140-A1 IMIDAZOLYL-AMINO-PYRAZINE-CARBONITRILS AS CHK-1 INHIBITORS BENEVOLENTAI BIO LTD (GB) 2026-05-14 US disclosed
EP-4739681-A1 SUBSTITUTED THIAZOLE COMPOUNDS AS CDK2/4/6 INHIBITORS AND METHODS OF USE THEREOF Insilico Medicine IP Limited (HK) 2026-05-13 EP disclosed
US-20260125384-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 US disclosed
US-20260125375-A1 SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS PFIZER INC. (US) 2026-05-07 US disclosed
WO-2004050022-A2 PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2004-06-17 WO disclosed
WO-2003080574-A1 PIPERIDINE OR 8-AZA-BICYCLO[3.2.1]OCT-3-YL DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5) ASTRAZENECA AB (SE) 2003-10-02 WO disclosed
WO-2003045912-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2003-06-05 WO disclosed
EP-1233013-A1 NOVEL PHENYLALANINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2002-08-21 EP disclosed
US-5322848-A Analgesics DR. LO ZEMBELETTI S.P.A. (IT) 1994-06-21 US disclosed
EP-0501997-A1 N-ACYL-SUBSTITUTED AZACYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICALS. ZAMBELETTI SPA L (IT) 1992-09-09 EP disclosed
WO-1991008206-A1 N-ACYL-SUBSTITUTED AZACYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICALS DR. LO. ZAMBELETTI S.P.A. (IT) 1991-06-13 WO disclosed